LONG QT SYNDROME CONGENITAL

LONG QT SYNDROME CONGENITAL was reported 90 times

LONG QT SYNDROME CONGENITAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anticholinergic [EPC] 4 0.0002
1 General Anesthetic [EPC] 9 0.0002
2 Human Immunoglobulin G [EPC] 3 0.0001
3 Serotonin-3 Receptor Antagonist [EPC] 18 0.0001
4 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
5 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
6 Amide Local Anesthetic [EPC] 6 0.0001
7 Fluoroquinolone Antibacterial [EPC] 8 0.0001
8 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
9 Antiarrhythmic [EPC] 6 0.0001
10 Ester Local Anesthetic [EPC] 3 0.0001
11 Central Nervous System Stimulant [EPC] 5 0.0001
12 Rifamycin Antibacterial [EPC] 2 0.0001
13 Aminoglycoside Antibacterial [EPC] 2 0.0000
14 Non-Standardized Chemical Allergen [EPC] 3 0.0000
15 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
16 Azole Antifungal [EPC] 3 0.0000
17 Macrolide Antimicrobial [EPC] 1 0.0000
18 Dihydropyridine Calcium Channel Blocker [EPC] 5 0.0000
19 Opioid Agonist [EPC] 4 0.0000
20 Mood Stabilizer [EPC] 3 0.0000
21 Osmotic Laxative [EPC] 4 0.0000
22 Loop Diuretic [EPC] 6 0.0000
23 beta-Adrenergic Blocker [EPC] 4 0.0000
24 Proton Pump Inhibitor [EPC] 7 0.0000
25 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
26 Prostaglandin Analog [EPC] 1 0.0000
27 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
28 Vitamin D [EPC] 3 0.0000
29 Vitamin B12 [EPC] 3 0.0000
30 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
31 Benzodiazepine [EPC] 5 0.0000
32 Vitamin C [EPC] 3 0.0000
33 Corticosteroid [EPC] 7 0.0000
34 Anti-epileptic Agent [EPC] 1 0.0000
35 Alkylating Drug [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000